Lincoln National Corp Exact Sciences Corp Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$56.27 - $73.77 $138,367 - $181,400	-2,459 Reduced 31.46%	5,358 $370,000
Q4 2023 Feb 06, 2024	BUY	$59.06 - $75.72 $33,664 - $43,160	570 Added 7.87%	7,817 $578,000
Q3 2023 Nov 03, 2023	BUY	$65.94 - $99.04 $65,214 - $97,950	989 Added 15.8%	7,247 $494,000
Q2 2023 Aug 04, 2023	BUY	$62.68 - $95.05 $15,983 - $24,237	255 Added 4.25%	6,258 $587,000
Q1 2023 May 01, 2023	BUY	$47.19 - $70.77 $30,390 - $45,575	644 Added 12.02%	6,003 $407,000
Q4 2022 Feb 07, 2023	BUY	$30.35 - $53.15 $162,645 - $284,830	5,359 New	5,359 $265,000
Q2 2022 Aug 02, 2022	BUY	$35.61 - $76.23 $14,956 - $32,016	420 Added 8.58%	5,315 $209,000
Q1 2022 May 09, 2022	SELL	$57.56 - $82.54 $6,158 - $8,831	-107 Reduced 2.14%	4,895 $342,000
Q4 2021 Jan 26, 2022	SELL	$72.5 - $100.68 $18,052 - $25,069	-249 Reduced 4.74%	5,002 $389,000
Q3 2021 Nov 05, 2021	BUY	$90.24 - $124.05 $26,801 - $36,842	297 Added 6.0%	5,251 $501,000
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $100,216 - $149,018	-1,070 Reduced 17.76%	4,954 $616,000
Q4 2020 Feb 05, 2021	BUY	$99.61 - $142.12 $9,761 - $13,927	98 Added 1.65%	6,024 $798,000
Q3 2020 Nov 09, 2020	BUY	$72.92 - $102.01 $16,698 - $23,360	229 Added 4.02%	5,926 $604,000
Q2 2020 Jul 31, 2020	SELL	$55.75 - $92.75 $5,909 - $9,831	-106 Reduced 1.83%	5,697 $495,000
Q1 2020 Apr 24, 2020	BUY	$37.9 - $104.44 $38,127 - $105,066	1,006 Added 20.97%	5,803 $337,000
Q4 2019 Feb 07, 2020	BUY	$77.66 - $99.74 $32,228 - $41,392	415 Added 9.47%	4,797 $444,000
Q2 2019 Aug 06, 2019	SELL	$89.51 - $118.04 $44,755 - $59,020	-500 Reduced 10.24%	4,382 $517,000
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $137,967 - $214,809	-2,226 Reduced 31.32%	4,882 $423,000
Q3 2018 Nov 06, 2018	SELL	$48.29 - $80.6 $21,730 - $36,270	-450 Reduced 5.95%	7,108 $561,000
Q2 2018 Aug 08, 2018	SELL	$37.84 - $69.96 $57,970 - $107,178	-1,532 Reduced 16.85%	7,558 $452,000
Q1 2018 May 09, 2018	SELL	$39.82 - $57.53 $463,743 - $669,994	-11,646 Reduced 56.16%	9,090 $367,000
Q4 2017 Feb 13, 2018	BUY	$46.49 - $60.51 $482,008 - $627,367	10,368 Added 100.0%	20,736 $1.09 Million
Q3 2017 Oct 31, 2017	BUY	$37.05 - $47.12 $9,781 - $12,439	264 Added 2.61%	10,368 $489,000
Q2 2017 Aug 07, 2017	BUY	N/A	10,104	10,104 $357,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.02 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$911 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$824 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$694 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$384 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account